![]() |
|
|
Vol. 286, Issue 1, 497-508, July 1998
Central Nervous System Diseases Research, Pharmacia & Upjohn, Inc.,
Kalamazoo, Michigan (D.L.F., L.M.N., M.P.S., J.S.A., K.A.S., K.M.M.)
and
Department of Psychiatry, Case Western Reserve University,
Cleveland, Ohio (B.K.Y.)
Our studies examined the role of dopamine D4 receptors in the induction
of behavioral sensitization to amphetamine (Amp) and accompanying
neurochemical and molecular adaptive responses using a highly selective
D4 antagonist, PNU-101387G. Behavioral sensitization to an acute
challenge of Amp (2 mg/kg, s.c.) was observed in rats pretreated with
five daily doses of Amp (2 mg/kg/d, s.c.) followed by 7-day withdrawal.
Interestingly, coadministration of PNU-101387G with Amp during
pretreatment completely blocked the sensitized response to an acute Amp
challenge. The behavioral sensitization and its blockade by the D4
antagonist were observed in the absence of significant differences in
cerebellar Amp levels among the various pretreatment groups.
Accompanying behavioral sensitization were two postsynaptic
neuroadaptive responses: reduction in the ability of Amp to induce
c-fos gene expression in the infralimbic/ventral prelimbic
cortex and NT/N mRNA in the accumbal shell. However, concurrent
blockade of D4 receptors during Amp pretreatment prevented the
refractoriness in c-fos and NT/N responsiveness to acute
Amp. We observed also a presynaptic neuroplastic response associated with the behavioral sensitization: a significant augmentation in the
ability of Amp to increase extracellular dopamine concentrations in the
nucleus accumbens shell. As with the behavioral sensitization and
associated postsynaptic adaptive responses, concurrent administration of PNU-101387G with Amp during pretreatment blocked the augmentation in
Amp-induced dopamine release. Taken together, these data demonstrate that dopamine D4 receptors play an important role in the induction of
behavioral sensitization to Amp and accompanying adaptations in pre-
and postsynaptic neural systems associated with the mesolimbocortical dopamine projections.
This article has been cited by other articles:
![]() |
A. L. Brody, M. A. Mandelkern, R. E. Olmstead, D. Scheibal, E. Hahn, S. Shiraga, E. Zamora-Paja, J. Farahi, S. Saxena, E. D. London, et al. Gene Variants of Brain Dopamine Pathways and Smoking-Induced Dopamine Release in the Ventral Caudate/Nucleus Accumbens. Arch Gen Psychiatry, July 1, 2006; 63(7): 808 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ventura, S. Cabib, A. Alcaro, C. Orsini, and S. Puglisi-Allegra Norepinephrine in the Prefrontal Cortex Is Critical for Amphetamine-Induced Reward and Mesoaccumbens Dopamine Release J. Neurosci., March 1, 2003; 23(5): 1879 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Binder, B. Kinkead, M. J. Owens, and C. B. Nemeroff Neurotensin and Dopamine Interactions Pharmacol. Rev., December 1, 2001; 53(4): 453 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rubinstein, C. Cepeda, R. S. Hurst, J. Flores-Hernandez, M. A. Ariano, T. L. Falzone, L. B. Kozell, C. K. Meshul, J. R. Bunzow, M. J. Low, et al. Dopamine D4 Receptor-Deficient Mice Display Cortical Hyperexcitability J. Neurosci., June 1, 2001; 21(11): 3756 - 3763. [Abstract] [Full Text] [PDF] |
||||